NJ State Employees Deferred Compensation Plan - RA PHARMACEUTICALS INC ownership

RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 151 filers reported holding RA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 16.18 and the average weighting 0.6%.

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of RA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$329,0007,0000.06%
Other shareholders

There were no reported owners of RA PHARMACEUTICALS INC in Q1 2020.

NameSharesValueWeighting ↓
View complete list of RA PHARMACEUTICALS INC shareholders